Traws Pharma Q1 2026 Earnings Narrowed Loss Surpasses Expectations Amid PreRevenue Stage CCEL Q1 2026 Earnings Earnings Beat Expectations with Positive EPS FIS Q1 2026 Earnings EPS Beats Estimates by 464 as Profitability Takes Center Stage DOC Q1 2026 Earnings Staggering EPS Beat Highlights Strong Portfolio Performance GBDC Q1 2026 Earnings Significant EPS Miss Amid Challenging Market Conditions FATE Q1 2026 Earnings Narrows Loss Per Share Stock Rises on Improved Bottom Line